AllianceBernstein’s Alpine Immune Sciences Inc ALPN Stock Holding History

AllianceBernstein’s Portfolio ALPN Stock Details ALPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-41,290	Closed	-$1.64M	–	3339
2024 Q1	$1.64M	Buy	41,290 +11,250	+37%	+$332K	﹤0.01%	2026
2023 Q4	$573K	Buy	30,040 +11,540	+62%	+$160K	﹤0.01%	2543
2023 Q3	$212K	Buy	18,500 +2,680	+17%	+$33K	﹤0.01%	2940
2023 Q2	$163K	Buy	+15,820	New	+$143K	﹤0.01%	3020

AllianceBernstein's ALPN Position: Q2 2024 in Review

AllianceBernstein sold out of Alpine Immune Sciences Inc (ALPN) in Q2 2024, closing a stake of 41,290 shares — an estimated $1.64M sold.

AllianceBernstein first reported a position in ALPN in Q2 2023 and held it in 4 quarters. The position peaked at $1.64M in Q1 2024. 0 funds tracked by Wall St. Rank hold ALPN as of Q2 2024.

AllianceBernstein reported no remaining Alpine Immune Sciences Inc position as of Q2 2024 after selling out during the quarter.
AllianceBernstein sold 41,290 Alpine Immune Sciences Inc shares in Q2 2024, an estimated $1.64M.
AllianceBernstein first reported a position in Alpine Immune Sciences Inc in Q2 2023 and held it in 4 quarters.
AllianceBernstein's Alpine Immune Sciences Inc position peaked at $1.64M in Q1 2024.
0 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q2 2024.

Based on AllianceBernstein's 13F filing for Q2 2024, filed 14 Aug 2024.